Elsevier

Metabolism

Volume 29, Issue 5, May 1980, Pages 445-454
Metabolism

Insulin-independent diabetes mellitus: Metabolic characteristics

https://doi.org/10.1016/0026-0495(80)90170-5Get rights and content

Abstract

Glucose intolerance in patients with insulin-independent diabetes mellitus can theoretically arise from a loss of normal tissue sensitivity to insulin (insulin resistance) and/or from a decrease in insulin secretory capacity. A review of available literature indicates that both of these defects can exist in these patients. Thus, patients with insulin-independent diabetes mellitus demonstrate a decrease in tissue sensitivity to insulin, and there is a significant relationship between the severity of the glucose intolerance and the magnitude of the insulin resistance in these patients. The relationship between glucose intolerance and insulin secretion in patients with insulin-independent diabetes is more complicated. Patients with mild glucose intolerance tend to have an insulin response to glucose equal to or greater than normal. As the severity of glucose intolerance increases, the insulin response becomes attenuated and patients with severe fasting hyperglycemia become hypoinsulinemic. On the basis of these changes in insulin resistance and insulin secretion, two formulations concerning the pathogenesis of insulin-independent diabetes seem possible. The first is based upon the premise that the basic defect in patients with insulin-independent diabetes is loss of normal tissue sensitivity to insulin. In an effort to maintain glucose homeostasis, increased amounts of insulin are secreted. However, as the need to augment insulin secretion continues, the beta cell may lose the ability to compensate, and frank hypoinsulinemia can supervene. Alternatively, patients with insulin-independent diabetes can be viewed as representing a metabolically heterogeneous group composed of individuals with various degrees of increased insulin resistance and decreased insulin secretory capacity. In this situation, the degree of glucose intolerance will vary as a function of the relative severity of the two metabolic defects. These relatively simple formulations are confounded by the fact that insulin deficiency can lead to insulin resistance, and vice versa, and that obesity will greatly affect insulin resistance and insulin secretion. Thus, the degree of glucose intolerance in any individual is the result of a complex series of relationships between both intrinsic and environmental factors controlling insulin resistance and insulin secretion. Our ability to understand the pathogenesis of insulin-independent diabetes mellitus will depend upon better understanding of these various relationships.

References (42)

  • KM West

    Standardization of definition, classification, and reporting in diabetes-related epidemiologic studies

    Diabetes Care

    (1979)
  • S-W Shen et al.

    Comparison of impedance to insulin mediated glucose uptake in normal and diabetic subjects

    J Clin Invest

    (1970)
  • Standardization of the oral glucose tolerance test

    Diabetes

    (1969)
  • H Ginsberg et al.

    Further evidence that insulin resistance exists in patients with chemical diabetes

    Diabetes

    (1974)
  • H Ginsberg et al.

    Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia

    J Clin Invest

    (1975)
  • G Kimmerling et al.

    Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus

    Diabetes

    (1976)
  • GM Reaven et al.

    Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes

    Diabetologia

    (1977)
  • BM Davis et al.

    Defect in glucose removal in nonketotic diabetic patients with fasting hyperglycemia

    Diabetes

    (1979)
  • GM Reaven et al.

    An attempt to define the nature of chemical diabetes using a multidimensional analysis

    Diabetologia

    (1979)
  • Y Harano et al.

    Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity

    J Clin Endocrinol Metab

    (1977)
  • R DeFronzo et al.

    Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes

    J Clin Invest

    (1979)
  • Cited by (0)

    View full text